Share a compound : 59608-01-4

With the rapid development of chemical substances, we look forward to future research findings about 59608-01-4.

As we all know, there are many different methods for the synthesis of a compound, and people can choose the synthesis method that suits their own laboratory according to the actual situation. 59608-01-4, name is 3-(Pyridin-3-yl)propiolic acid, molecular formula is C8H5NO2, The compound is widely used in many fields, so it is necessary to find a new synthetic route. The downstream synthesis method of this compound is introduced below. Computed Properties of C8H5NO2

To a solution of D-2 (0.5 g, 3.4 mmol) in CH2CI2 (50mL) at 0C, Oxalyl chloride (0,86 g, 6.8 mmol) and 2 drops of DMF were added. The mixture was stirred at reflux over night. The solvent was removed to yield a light yellow oil.

With the rapid development of chemical substances, we look forward to future research findings about 59608-01-4.

Reference:
Patent; NOVARTIS AG; NOVARTIS PHARMA GMBH; WO2008/14311; (2008); A2;,
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem

Share a compound : 59608-01-4

With the rapid development of chemical substances, we look forward to future research findings about 59608-01-4.

As we all know, there are many different methods for the synthesis of a compound, and people can choose the synthesis method that suits their own laboratory according to the actual situation. 59608-01-4, name is 3-(Pyridin-3-yl)propiolic acid, molecular formula is C8H5NO2, The compound is widely used in many fields, so it is necessary to find a new synthetic route. The downstream synthesis method of this compound is introduced below. Computed Properties of C8H5NO2

To a solution of D-2 (0.5 g, 3.4 mmol) in CH2CI2 (50mL) at 0C, Oxalyl chloride (0,86 g, 6.8 mmol) and 2 drops of DMF were added. The mixture was stirred at reflux over night. The solvent was removed to yield a light yellow oil.

With the rapid development of chemical substances, we look forward to future research findings about 59608-01-4.

Reference:
Patent; NOVARTIS AG; NOVARTIS PHARMA GMBH; WO2008/14311; (2008); A2;,
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem